Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Hemispherx Biopharma, Inc.
(NY:
HEB
)
0.2500
USD
UNCHANGED
Official Closing Price
/ Updated:
6:40 PM EDT, Jun 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
717,918
Open
0.2415
Bid (Size)
0.2211 (300)
Ask (Size)
0.2795 (500)
Prev. Close
0.2500
Today's Range
0.2415 - 0.2580
52wk Range
0.1900 - 1.100
Shares Outstanding
167,229,903
Dividend Yield
N/A
Top News
More News
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2013
May 08, 2013
from
GlobeNewswire News Releases
BioCryst (BCRX) Continues Higher on Latest Bird Flu Death
April 12, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8250037 for the full story.
Read More
from
StreetInsider.com News Articles
More News
Read More
Hemispherx Biopharma Announces Financial Results for the Year Ended December 31, 2012
March 18, 2013
from
GlobeNewswire News Releases
Hemispherx Biopharma Gains Broad Treatment Expansion for Alferon N Injection(R) in Argentina
March 04, 2013
from
GlobeNewswire News Releases
UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Hemispherx Biopharma, Inc. of Class Action Lawsuit and the Deadline of February 22, 2013 to Seek a Lead Plaint
February 20, 2013
from
Business Wire News Releases
Rosen Law Firm Reminds Hemispherx Biopharma Investors of Important February 22, 2013 Deadline -- HEB
February 16, 2013
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of Hemispherx Biopharma of Upcoming Deadline -- HEB
February 15, 2013
from
GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders of Hemispherx Biopharma of Upcoming Deadline -- HEB
February 08, 2013
from
GlobeNewswire News Releases
ShinesRooms Research on Gilead and Hemispherx: Biotech Companies Seek New Pastures
February 07, 2013
from
ACCESSWIRE
Free Research Reports on BIDU, HEB, IDIX and YUM Issued by the Bedford Report
February 06, 2013
from
Marketwired News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here